Elis: completes divestment of IHSS division
(CercleFinance.com) - Elis announced that it has completed the sale of 100% of the IHSS division of Clinical Solutions in the UK, one of the two divisions of Clinical Solutions, which was one of the two businesses belonging to Berendsen prior to its acquisition by Elis in 2017.
"La cession [à Vamed] d'IHSS clôture ainsi le processus de vente de Clinical Solutions, qui avait été scindé en deux ; la division Rocialle & Guardian a été cédée en août dernier", Elis said.
Elis said that the sale of IHSS (to Vamed) thus closes the sales process of Clinical Solutions, which was split in two; the Rocialle & Guardian division was sold last August.
In order to remain focused on its core business, in H1 2018 Elis already announced that it was going to sell all of Clinical Solutions.
Copyright (c) 2019 CercleFinance.com. All rights reserved.
"La cession [à Vamed] d'IHSS clôture ainsi le processus de vente de Clinical Solutions, qui avait été scindé en deux ; la division Rocialle & Guardian a été cédée en août dernier", Elis said.
Elis said that the sale of IHSS (to Vamed) thus closes the sales process of Clinical Solutions, which was split in two; the Rocialle & Guardian division was sold last August.
In order to remain focused on its core business, in H1 2018 Elis already announced that it was going to sell all of Clinical Solutions.
Copyright (c) 2019 CercleFinance.com. All rights reserved.